Sort
23,748 grants matching “melanoma”
Biology of Perlecan in Cancer
$329,925Thomas Jefferson University · R01 · FY2003 · CA
The Role of WSB1 in Tumorigenesis
$329,925Zhenkun Lou · Mayo Clinic Rochester · R01 · FY2016 · CA
Biology of Perlecan in Cancer
$329,925Thomas Jefferson University · R01 · FY2002 · CA
The Role of WSB1 in Tumorigenesis
$329,925Zhenkun Lou · Mayo Clinic Rochester · R01 · FY2015 · CA
The role of a histone H4 phosphorylation in drug resistance
$329,925Zhiguo Zhang · Mayo Clinic Rochester · R01 · FY2015 · CA
Role of Notch Signaling in Regulation of Autophagy in Melanoblast and Melanoma
$329,925Masatake Osawa · Massachusetts General Hospital · R01 · FY2009 · CA
The Role of WSB1 in Tumorigenesis
$329,925Zhenkun Lou · Mayo Clinic Rochester · R01 · FY2017 · CA
Elucidating a novel molecular biomarker for castration-resistant prostate cancer
$329,925Nima Sharifi · Ut Southwestern Medical Center · R01 · FY2012 · CA
Genetic Approaches to Immune Adjuvants
$329,889Alan N. Houghton · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA
The pluripotency regulator Prdm14 initiates cancer by epigenetic mechanisms
$329,810Monica Jean Justice · Hospital For Sick Chldrn (Toronto) · R01 · FY2016 · CA
The pluripotency regulator Prdm14 initiates cancer by epigenetic mechanisms
$329,810Monica Jean Justice · Hospital For Sick Chldrn (Toronto) · R01 · FY2015 · CA
Regulation and Role of miR-183-96-182 in Melanocyte Differentiation and Melanoma
$329,801Eva Hernando · New York University School Of Medicine · R01 · FY2013 · CA
Cancer and Stroma-Targeted Immunotherapy with a Gentically Modified DC Vaccine
$329,757Xiaotong Song · Baylor College Of Medicine · R01 · FY2012 · CA
Vascular Survival Governed by Integrin Ligation State
$329,656Scripps Research Institute · R01 · FY2002 · CA
Vascular Survival Governed by Integrin Ligation State
$329,656Scripps Research Institute · R01 · FY2003 · CA
Vascular Survival Governed by Integrin Ligation State
$329,656Scripps Research Institute · R01 · FY2004 · CA
Molecularly Engineered Constructs for anti-CD20 Directed Therapeutics
$329,558Andrew A. Raubitschek · Beckman Research Institute/City Of Hope · P50 · FY2007 · CA
Novel focused ultrasound enhanced calreticulin-nanoparticle for immune primed melanoma immunotherapy
$329,555Ashish Ranjan · Oklahoma State University Stillwater · R37 · FY2021 · CA
Nucleoporin NUP205-driven Novel Pathway in Melanoma Tumor Growth and Metastasis
$329,502Narendra Wajapeyee · University Of Alabama At Birmingham · R01 · FY2019 · CA
The role of pheomelanin in cutaneous melanoma
$329,488Rutao Cui · Boston University Medical Campus · R01 · FY2014 · CA
Biological activity of ras oncogenes
$329,406Channing J Der · Univ Of North Carolina Chapel Hill · R01 · FY2006 · CA
BMP7 in melanoma niche morphogenesis and homeostasis
$329,387Mei-Yu Hsu · Boston University Medical Campus · R01 · FY2012 · CA
Project 3: MITF in Drug Resistance and Metabolism in Melanoma
$329,332Jeffrey W Smith · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2018 · CA
Project 3: MITF in Drug Resistance and Metabolism in Melanoma
$329,332Jeffrey W Smith · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2020 · CA
Employing Humanized Microbiome Mice to Understand Immune Activation and Translational Therapeutic Potential in Glioblastoma
$329,317Braden Cox McFarland · University Of Alabama At Birmingham · R01 · FY2023 · CA